UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Riluzole in the Treatment of Mood and Anxiety Disorders

CNS drugs, 2008-01, Vol.22 (9), p.761-786

2008

Volltextzugriff (PDF)

Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant

Advances in therapy, 2021-10, Vol.38 (10), p.5209-5220

2021

Volltextzugriff (PDF)

The HIV-1 maturation inhibitor, EP39, interferes with the dynamic helix-coil equilibrium of the CA-SP1 junction of Gag

European journal of medicinal chemistry, 2020-10, Vol.204, p.112634-112634, Article 112634

2020

Volltextzugriff (PDF)

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

Psychopharmacology, 2006-02, Vol.184 (2), p.254-256

2006

Volltextzugriff (PDF)

Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis

Expert review of pharmacoeconomics & outcomes research, 2022-01, Vol.22 (1), p.155-166

2022

Volltextzugriff (PDF)

Renal complications of Fabry disease

Current pharmaceutical design, 2013-10, Vol.19 (33), p.6046-6050

2013

Volltextzugriff (PDF)

Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site

European journal of medicinal chemistry, 2013-04, Vol.62, p.453-465

2013

Volltextzugriff (PDF)

Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies

Advances in therapy, 2023-03, Vol.40 (3), p.1141-1152

2023

Volltextzugriff (PDF)

Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation

Antiviral research, 2019-04, Vol.164, p.162-175

2019

Volltextzugriff (PDF)

Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305)

Advances in therapy, 2023-02, Vol.40 (2), p.585-600

2023

Volltextzugriff (PDF)

Inappropriate prescribing in patients with kidney disease: A rapid review of prevalence, associated clinical outcomes and impact of interventions

Basic & clinical pharmacology & toxicology, 2024-04, Vol.134 (4), p.439-459

2024

Volltextzugriff (PDF)

In vitro susceptibility of carbapenem-resistant Enterobacterales to eravacycline - the first report from Croatia

Journal of chemotherapy (Florence), 2022-02, Vol.34 (1), p.67-70

2022

Volltextzugriff (PDF)

Vanishing Bile Duct Syndrome Associated with Azithromycin in a 62‐Year‐Old Man

Basic & clinical pharmacology & toxicology, 2010-01, Vol.106 (1), p.62-65

2010

Volltextzugriff (PDF)

Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-up

Journal of clinical psychopharmacology, 2008-06, Vol.28 (3), p.363-367

2008

Volltextzugriff (PDF)

Guttiferone A Aggregates Modulate Silent Information Regulator 1 (SIRT1) Activity

Journal of medicinal chemistry, 2016-10, Vol.59 (20), p.9560-9566

2016

Volltextzugriff (PDF)

Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: Diclofenac-induced gastrointestinal, liver, and encephalopathy lesions

Life sciences (1973), 2011-03, Vol.88 (11), p.535-542

2011

Volltextzugriff (PDF)

Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder

Psychopharmacology, 2003-05, Vol.167 (2), p.219-220

2003

Volltextzugriff (PDF)

Phosphinic Derivatives as New Dual Enkephalin-Degrading Enzyme Inhibitors: Synthesis, Biological Properties, and Antinociceptive Activities

Journal of medicinal chemistry, 2000-04, Vol.43 (7), p.1398-1408

2000

Volltextzugriff (PDF)

Pentadecapeptide BPC 157, in Clinical Trials as a Therapy for Inflammatory Bowel Disease (PL14736), Is Effective in the Healing of Colocutaneous Fistulas in Rats: Role of the Nitric Oxide-System

Journal of Pharmacological Sciences, 2008, Vol.108(1), pp.7-17

2008

Volltextzugriff (PDF)

Rational Design, Structure, and Biological Evaluation of Cyclic Peptides Mimicking the Vascular Endothelial Growth Factor

Journal of medicinal chemistry, 2007-10, Vol.50 (21), p.5135-5146

2007

Volltextzugriff (PDF)

Pharmacodynamics of selective inhibition of γ-secretase by avagacestat

The Journal of pharmacology and experimental therapeutics, 2013-03, Vol.344 (3), p.686-695

2013

Volltextzugriff (PDF)

A paradigm to investigate the regulation of cocaine self-administration in human cocaine users : a randomized trial

Psychopharmacologia, 2006-04, Vol.185 (3), p.306-314

2006

Volltextzugriff (PDF)

On-resin cyclization of peptide ligands of the Vascular Endothelial Growth Factor Receptor 1 by copper(I)-catalyzed 1,3-dipolar azide–alkyne cycloaddition

Bioorganic & medicinal chemistry letters, 2007-10, Vol.17 (20), p.5590-5594

2007

Volltextzugriff (PDF)

Self-reported paranoia during laboratory “binge” cocaine self-administration in humans

Pharmacology, biochemistry and behavior, 2006-02, Vol.83 (2), p.249-256

2006

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Riluzole in the Treatment of Mood and Anxiety Disorders

Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant

The HIV-1 maturation inhibitor, EP39, interferes with the dynamic helix-coil equilibrium of the CA-SP1 junction of Gag

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis

Renal complications of Fabry disease

Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site

Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies

Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation

Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305)

Inappropriate prescribing in patients with kidney disease: A rapid review of prevalence, associated clinical outcomes and impact of interventions

New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotection

In vitro susceptibility of carbapenem-resistant Enterobacterales to eravacycline - the first report from Croatia

Vanishing Bile Duct Syndrome Associated with Azithromycin in a 62‐Year‐Old Man

Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-up

Guttiferone A Aggregates Modulate Silent Information Regulator 1 (SIRT1) Activity

Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: Diclofenac-induced gastrointestinal, liver, and encephalopathy lesions

Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder

Phosphinic Derivatives as New Dual Enkephalin-Degrading Enzyme Inhibitors: Synthesis, Biological Properties, and Antinociceptive Activities

Pentadecapeptide BPC 157, in Clinical Trials as a Therapy for Inflammatory Bowel Disease (PL14736), Is Effective in the Healing of Colocutaneous Fistulas in Rats: Role of the Nitric Oxide-System

Rational Design, Structure, and Biological Evaluation of Cyclic Peptides Mimicking the Vascular Endothelial Growth Factor

Pharmacodynamics of selective inhibition of γ-secretase by avagacestat

A paradigm to investigate the regulation of cocaine self-administration in human cocaine users : a randomized trial

On-resin cyclization of peptide ligands of the Vascular Endothelial Growth Factor Receptor 1 by copper(I)-catalyzed 1,3-dipolar azide–alkyne cycloaddition

Self-reported paranoia during laboratory “binge” cocaine self-administration in humans

Aktive Filter

Suchergebnisse filtern